home / stock / tlis / tlis news


TLIS News and Press, Talis Biomedical Corporation From 07/27/21

Stock Information

Company Name: Talis Biomedical Corporation
Stock Symbol: TLIS
Market: NASDAQ
Website: talis.bio

Menu

TLIS TLIS Quote TLIS Short TLIS News TLIS Articles TLIS Message Board
Get TLIS Alerts

News, Short Squeeze, Breakout and More Instantly...

TLIS - Talis Biomedical to Announce Second Quarter 2021 Financial Results on August 10, 2021

MENLO PARK, Calif., July 27, 2021 (GLOBE NEWSWIRE) -- Talis Biomedical Corporation ("TLIS"), a company dedicated to developing innovative molecular diagnostic tests for infectious diseases at the point-of-care, today announced that it will release financial results for the second quarter af...

TLIS - Tracking Baker Brothers Portfolio - Q1 2021 Update

Baker Brothers’ 13F portfolio value decreased from $26.54B to $23.07B this quarter. The large stake in Alexion Pharmaceuticals was decreased during the quarter. The top three positions are Seagen, BeiGene, and Incyte Corporation and they add up to almost ~57% of the portfol...

TLIS - Talis Biomedical Corporation (TLIS) CEO Brian Coe on Q1 2021 Results - Earnings Call Transcript

Talis Biomedical Corporation (TLIS) Q1 2021 Earnings Conference Call May 11, 2021, 04:30 PM ET Company Participants Emily Fawcett - SVP Corporate Communications and IR Brian Coe - CEO Roger Moody - CFO Conference Call Participants Tycho Peterson - JP Morgan Ivy Ma - Bank of America Merrill Ly...

TLIS - Talis Biomedical EPS of -$4.61

Talis Biomedical (TLIS): Q1 EPS of -$4.61 may not be comparable to consensus of -$0.78.Revenue of $7M beats by $1.62M.Press Release For further details see: Talis Biomedical EPS of -$4.61

TLIS - Talis Biomedical Announces First Quarter 2021 Financial Results and Business Progress

MENLO PARK, Calif., May 11, 2021 (GLOBE NEWSWIRE) -- Talis Biomedical Corporation (Nasdaq: TLIS), a company dedicated to developing innovative molecular diagnostic tests for infectious diseases at the point-of-care, today reported financial results and business progress for the first quarte...

TLIS - Talis Biomedical to Announce First Quarter 2021 Financial Results on May 11, 2021

MENLO PARK, Calif., May 04, 2021 (GLOBE NEWSWIRE) -- Talis Biomedical Corporation ("TLIS"), a company dedicated to developing innovative molecular diagnostic tests for infectious diseases at the point-of-care, today announced that it will release financial results for the first quarter afte...

TLIS - Talis Biomedical to Participate in Upcoming BofA Securities 2021 Virtual Healthcare Conference

MENLO PARK, Calif., April 28, 2021 (GLOBE NEWSWIRE) -- Talis Biomedical Corporation (“TLIS”), a company dedicated to developing innovative molecular diagnostic tests for infectious diseases at the point-of-care, today announced that the company will be participating in the Bof...

TLIS - New Stocks to Watch at Investor Ideas in Biotech, Tech, Mining and Real Estate

Point Roberts, WA and Delta, BC - April 16, 2021 (Investorideas.com Newswire) Investorideas.com , a global news source and leading retail investor and trader resource, announces its weekly roundup of stocks to watch in Biotech, Tech, Mining and Real Estate. Today's stocks have been adde...

TLIS - INPX, NCTY, SEEL and INTZ among midday movers

Gainers: Wilhelmina International (WHLM) +25%.Kaleido Biosciences (KLDO) +14%.Ardelyx (ARDX) +14%.PLBY Group (PLBY) +14%.Talis Biomedical (TLIS) +14%.Wah Fu Education (WAFU) +12%.Seelos Therapeutics (SEEL) +11%Inpixon (INPX) +11%.BCTG Acquisition (BCTG) +10%.Ballantyne Strong (...

TLIS - Talis Appoints Jeryl Hilleman to Board of Directors

MENLO PARK, Calif., March 18, 2021 (GLOBE NEWSWIRE) -- Talis Biomedical Corporation (Nasdaq: TLIS), a company dedicated to developing innovative molecular diagnostic tests for infectious diseases at the point-of-care, today announced the appointment of Jeryl “Jeri” Hillema...

Previous 10 Next 10